Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
IPO Year: 2022
Exchange: NYSE
Website: https://www.ehab.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/14/2024 | $8.50 | Underperform → Market Perform | Leerink Partners |
| 5/9/2024 | $14.00 → $8.75 | Buy → Hold | Jefferies |
| 3/7/2024 | $9.50 | Sell → Neutral | UBS |
| 12/12/2023 | $12.00 | Market Perform | TD Cowen |
| 6/20/2023 | $10.00 | Underperform | SVB Securities |
| 3/16/2023 | $15.00 | Neutral | Goldman |
| 12/13/2022 | $18.00 | Market Perform | CJS Securities |
| 12/8/2022 | $12.00 | Sell | UBS |
| 12/6/2022 | $17.00 | Buy | Stifel |
| 10/14/2022 | Perform | Oppenheimer |
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
3 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
Company to host a conference call tomorrow, November 7, 2024, at 10 a.m. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2024. "Our continued progress in our strategies during the third quarter resulted in Adjusted EBITDA growth year over year and strong free cash flow generation that led to further debt reduction," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "The payor innovation strategy continues to foster Medicare Advantage growth in our home health segment, and average daily census continues to grow in our hospice segment." QUARTERLY PERFORMAN
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the third quarter ended Sept. 30, 2024, on Nov. 6, 2024, and host a webcast and conference call on Nov. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Nov. 7, 2024 10 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/164004764 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice Enhabit H
Enhabit, Inc. (NYSE:EHAB), ("Enhabit" or the "Company"), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Ms. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities. Enhabit has initiated a comprehensive search to identify the Company's next chief financial officer. "Crissy has made important contributions to Enhabit since we became a public company just over two years ago," said Barb Jacobsmeyer, president and CEO of Enhabit. "Her deep commitment to our employees, patients, partners and stockholders, as well as her insights and financial acumen, have contribu
Company to host a conference call tomorrow, August 7, 2024, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2024. "The second quarter marked our third sequential quarter demonstrating the success of our strategies," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "In our home health segment, our total admissions growth of 6.4% was driven by our payor innovation strategy and our focus on improved utilization of our clinical resources. In our hospice segment, we continued to make steady progress in growing our census, with average daily census in
Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Unaudited Preliminary Results for the Second Quarter Ended June 30, 2024 Adjusted EBITDA* in the range of $24.5 million to $25.0 million Reduced bank debt by $15 million, including a $10 million payment on Enhabit's revolving credit facility 43% of Enhabit's non-Medicare visits shifting to payor innovation contracts at improved rates, an incr
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2024, on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Aug. 7, 2024 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/154318091 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice
Company to host a conference call tomorrow, May 9, 2024, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2024. "Our momentum exiting 2023 and through the first quarter of 2024 instills confidence and excitement in our strategy and team," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "Our strong start to 2024 is a result of our team's continued focus on our operational strategies. Additional frontline clinicians, more and better home health payor contracts and controlling general and administrative expenses were the key drivers of our performa
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2024, on May 8, 2024, and host a webcast and conference call on May 9, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. May 9, 2024 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/834974223 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice Enh
Company to host a conference call tomorrow, March 7, 2024, at 10 A.M. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended December 31, 2023. "Persistent focus on our Company's strategies drove our positive fourth quarter results," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "Payor innovation success, including the finalization of another new national contract, continued success with our people strategy and strong performance in our quality outcomes are but a few of our high points for the end of 2023 and our start to 2024. We are excited about our future and our a
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2023, on March 6, 2024, and host a webcast and conference call on March 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 7, 2024 10:00 a.m. Eastern Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/272381846 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health &
10-Q - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
10-Q - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
DEFA14A - Enhabit, Inc. (0001803737) (Filer)
Reiterates that Two Leading Proxy Advisory Firms Have Recommended Stockholders Support Meaningful Change to Enhabit's BoardReminds Stockholders that Enhabit Has Historically Made Excuses for Poor Performance and Empty PromisesUnderscores Opportunity Stockholders Have to Add Industry-Specific Expertise to Enhabit's Board at the Annual Meeting on July 25thAREX Capital Management, LP (together with its affiliates, "AREX"), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), today issued an open letter to its fellow stockholders asking them to address the deficiencies of Enhabit's current board of directors by ele
Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Unaudited Preliminary Results for the Second Quarter Ended June 30, 2024 Adjusted EBITDA* in the range of $24.5 million to $25.0 million Reduced bank debt by $15 million, including a $10 million payment on Enhabit's revolving credit facility 43% of Enhabit's non-Medicare visits shifting to payor innovation contracts at improved rates, an increase f
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2F4b216008-24ac-4184-9324-3ce8da548a35.usrfiles.com%2Fugd%2F4b2160_2a4b9d87603040aca08fa852fe969a2d.pdf&esheet=54090927&newsitemid=20240705086860&lan=en-US&anchor=Enhabit%26%238217%3Bs+Excuses+and+Empty+Promises&index=1&md5=a39bf52df03457cf5c388c4f47b336bb
Recent Results Demonstrate Improving Performance Despite HeadwindsBoard Has Taken Decisive Actions in Light of the Challenges Faced by Enhabit Since the SpinEnhabit's Proposed Board is Specifically Designed to Possess Relevant Industry and Public Company Oversight ExpertiseAREX's Proposal to Take Control of the Board is Not in the Best Interests of StockholdersStockholders Urged to Vote FOR Enhabit's Director Nominees on the YELLOW Proxy CardEnhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced that it has posted an investor presentation today in connection with its Annual Meeting of Stockholders (the "2024 Annual Meeting") scheduled for July 25, 2024. Stockh
B of A Securities analyst Joanna Gajuk maintains Enhabit (NYSE:EHAB) with a Underperform and lowers the price target from $9 to $8.
Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming 2024 annual meeting of stockholders (the "2024 Annual Meeting") scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting. In connection with the filing of its definitive proxy statement, Enhabit is mailing a letter to stockholders. Enhabit's definitive proxy materials and other materials regarding the Board of Directors' recommendation for the 2024 Annual Meeting can be f
The Company is filing a preliminary proxy statement because AREX Capital Management, LP has notified the Company that it intends to nominate seven candidates for election to the Company's nine-member board at the 2024 Annual Meeting. On May 8, 2024, having received no formal proposals, the Company announced that the Board had unanimously determined to terminate the strategic review.
Throughout the last three months, 5 analysts have evaluated Enhabit (NYSE:EHAB), offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 4 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 2 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $10.35, a high estimate of $14.00, and a low estimate of $8.50. This current average represents a 24.29% decrease from the previo
Leerink Partners analyst Whit Mayo upgrades Enhabit (NYSE:EHAB) from Underperform to Market Perform and announces $8.5 price target.
Jefferies analyst Brian Tanquilut downgrades Enhabit (NYSE:EHAB) from Buy to Hold and lowers the price target from $14 to $8.75.
Seasoned Industry Executive Brings Significant Financial Operations Expertise and Track Record of Driving Growth and Value Creation Enhabit, Inc. (NYSE:EHAB), ("Enhabit"), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon's appointment follows the previously announced transition of Crissy Carlisle, CFO. Mr. Solomon brings to Enhabit over 20 years of corporate strategy and finance experience, including eight years as CFO in the home health and hospice space and other industries. Mr. Solomon previously served as CFO of AccentCare, where he was responsible for financial pl
American Water Works Company, Inc. (NYSE:AWK) announced today that Stuart M. McGuigan has been appointed as an independent member of the company's board of directors, effective Oct. 29, 2024. "American Water is pleased to have Stuart join our board of directors," said Karl Kurz, Board Chair of American Water. "Stuart has more than 38 years of extensive experience in information technology and management including serving as the Chief Information Officer for national and global public companies, as well as a government agency. He will further strengthen our board, and we look forward to working with him." "We are honored to have Stuart become part of American Water's board," said M. Susan
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from
Files Definitive Proxy Materials and Mails Letter to Stockholders AREX's Unqualified Slate of Nominees Risks Detracting from the Talent Currently on the Board Urges Stockholders to Vote "FOR" Only Enhabit's Nine Nominees on the YELLOW Proxy Card Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming 2024 annual meeting of stockholders (the "2024 Annual Meeting") scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting.
Files Preliminary Proxy Statement; Elaborates on AREX Capital Management's Singular Focus in Demanding a Sale of the Company Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company") today announced that it has filed its preliminary proxy materials with the Securities and Exchange Commission (the "SEC") in connection with its upcoming 2024 annual meeting of stockholders (the "2024 Annual Meeting"). The preliminary proxy statement is available on the Investor Relations section of the Enhabit website at investors.ehab.com. The Company is filing a preliminary proxy statement because AREX Capital Management, LP (together with its affiliates and associates, "AREX") has notified the Company that
Board Appointments Support the Company's Previously Announced Board Transition Plan Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading national home health and hospice provider, today announced an agreement with Cruiser Capital Advisors LLC ("Cruiser") and Harbour Point Capital Management LP ("Harbour Point" ), which collectively own approximately 4.7% of the outstanding shares of Enhabit's common stock, pursuant to which Enhabit has appointed Stuart McGuigan and Barry Schochet to its board of directors, effective immediately. With these appointments the Company's board will expand temporarily to 13 directors. As Enhabit previously disclosed in May 2022 ahead of the complet
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced the appointment of Dylan Black as general counsel, effective January 2023. "We are excited to welcome Dylan to the Enhabit team," Enhabit President and CEO Barb Jacobsmeyer said. "He has served as a trusted legal advisor to many organizations, and we look forward to the leadership and contributions he will bring to Enhabit." Black brings more than 24 years of legal experience helping publicly traded companies. Most recently, Black served as a partner at Bradley Arant Boult Cummings LLP where he represented companies across various industries including health care, banking and environmental services. In
Leerink Partners upgraded Enhabit Inc. from Underperform to Market Perform and set a new price target of $8.50
Jefferies downgraded Enhabit Inc. from Buy to Hold and set a new price target of $8.75 from $14.00 previously
UBS upgraded Enhabit Inc. from Sell to Neutral and set a new price target of $9.50
TD Cowen initiated coverage of Enhabit Inc. with a rating of Market Perform and set a new price target of $12.00
SVB Securities initiated coverage of Enhabit Inc. with a rating of Underperform and set a new price target of $10.00
Goldman initiated coverage of Enhabit Inc. with a rating of Neutral and set a new price target of $15.00
CJS Securities initiated coverage of Enhabit Inc. with a rating of Market Perform and set a new price target of $18.00
UBS initiated coverage of Enhabit Inc. with a rating of Sell and set a new price target of $12.00
Stifel initiated coverage of Enhabit Inc. with a rating of Buy and set a new price target of $17.00
Oppenheimer initiated coverage of Enhabit Inc. with a rating of Perform
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced its participation in the upcoming BofA Securities 2024 Home Care Conference. Enhabit's President and Chief Executive Officer Barb Jacobsmeyer, incoming Chief Financial Officer Ryan Solomon, and Senior Vice President of Strategic Finance & Treasurer Jobie Williams will participate in a fireside chat on Tuesday, Dec. 10, at 9:00 a.m. EST. The fireside chat will be webcast live and available for replay at https://investors.ehab.com under the events and presentations link. About Enhabit Home Health & Hospice Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice prov
Seasoned Industry Executive Brings Significant Financial Operations Expertise and Track Record of Driving Growth and Value Creation Enhabit, Inc. (NYSE:EHAB), ("Enhabit"), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon's appointment follows the previously announced transition of Crissy Carlisle, CFO. Mr. Solomon brings to Enhabit over 20 years of corporate strategy and finance experience, including eight years as CFO in the home health and hospice space and other industries. Mr. Solomon previously served as CFO of AccentCare, where he was responsible for financial pl
Company to host a conference call tomorrow, November 7, 2024, at 10 a.m. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2024. "Our continued progress in our strategies during the third quarter resulted in Adjusted EBITDA growth year over year and strong free cash flow generation that led to further debt reduction," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "The payor innovation strategy continues to foster Medicare Advantage growth in our home health segment, and average daily census continues to grow in our hospice segment." QUARTERLY PERFORMAN
American Water Works Company, Inc. (NYSE:AWK) announced today that Stuart M. McGuigan has been appointed as an independent member of the company's board of directors, effective Oct. 29, 2024. "American Water is pleased to have Stuart join our board of directors," said Karl Kurz, Board Chair of American Water. "Stuart has more than 38 years of extensive experience in information technology and management including serving as the Chief Information Officer for national and global public companies, as well as a government agency. He will further strengthen our board, and we look forward to working with him." "We are honored to have Stuart become part of American Water's board," said M. Susan
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced its recognition by the Institute for Healthcare Improvement (IHI) as an Age-Friendly Health Systems Participant. Age-friendly Health Systems Participants are recognized for being on the journey to becoming an Age-Friendly Health System and have submitted a description of how they are putting four essential elements of care--the 4Ms--into practice with older patients. "We're participating in this vital movement to share our practices and learn from others providing Age-Friendly Care," said Bud Langham, executive vice president of clinical excellence & strategy at Enhabit. "This initiative aligns with our
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the third quarter ended Sept. 30, 2024, on Nov. 6, 2024, and host a webcast and conference call on Nov. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Nov. 7, 2024 10 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/164004764 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice Enhabit H
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced its participation in two upcoming investor conferences. Enhabit's President and Chief Executive Officer Barb Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in the following events: Jefferies Healthcare Services "Back to School" Summit and Bus Tour When: Aug. 28 Venue: 1 Hotel Nashville in Nashville, Tenn. 2024 Wells Fargo Healthcare Conference When: Investor meetings and a fireside chat on Sept. 5 Venue: Encore Boston Harbor in Boston, Mass. The fireside chat will be webcast live at 11 a.m. EDT and available for replay at https://investors.ehab.com under
Enhabit, Inc. (NYSE:EHAB), ("Enhabit" or the "Company"), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Ms. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities. Enhabit has initiated a comprehensive search to identify the Company's next chief financial officer. "Crissy has made important contributions to Enhabit since we became a public company just over two years ago," said Barb Jacobsmeyer, president and CEO of Enhabit. "Her deep commitment to our employees, patients, partners and stockholders, as well as her insights and financial acumen, have contribu
Company to host a conference call tomorrow, August 7, 2024, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2024. "The second quarter marked our third sequential quarter demonstrating the success of our strategies," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "In our home health segment, our total admissions growth of 6.4% was driven by our payor innovation strategy and our focus on improved utilization of our clinical resources. In our hospice segment, we continued to make steady progress in growing our census, with average daily census in
SC 13G - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)